Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
The Ministry of Health and Prevention (MOHAP) in the UAE Approves…
The Launch of AditxtScore™ for COVID-19 by Aditxt, Inc. (NASDAQ: ADTX)…
The FDA Grants Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) Fast Track Designation…
Hong Kong Health Experts Say Adolescents Should Receive One Dose Of…
Moderna Inc. (NASDAQ: MRNA) Receives New Drug Submission Approval From Health…
Finance
Sesen Bion (NASDAQ: SESN) Completes Vicineum Commercialization Plans Ahead Of Approval
Brooklyn Immunotherapeutics Inc (NYSEAMERICAN:BTX) Clinches An Exclusive License mRNA Gene Editing…
Amarin Corporation Plc (NASDAQ:AMRN) Receives Marketing Authorization For Icosapent Ethyl From…
Hollywall Entertainment Inc (OTCMKTS:HWAL): Under-the-Radar NFT Star in the Making? (PLBY,…
GeoVax Labs (GOVX) surges on positive sentiment
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:RIGL
Tag: NASDAQ:RIGL
Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) Reports $16.3 Million In Net Product Revenue...
Ward Sport
-
November 16, 2020
0
Dave Santos Joins Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) As EVP: Posts Improved...
Matt Wade
-
August 21, 2020
0
British Journal of Haematology Publishes Post-Hoc Analysis of Tavalisse for Adults...
Matt Wade
-
August 4, 2020
0
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Launches Investigator-Sponsored Trial of Fostamatinib in Patients...
Kate Hudson
-
July 22, 2020
0
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Rolls Out TAVLESSE In Europe
Gavins Felicity
-
July 14, 2020
0
Close
